Skip to main content

Want a detailed portfolio tracker?

Propanc Biopharma (PPCB) P/E (2020 - 2026)

Propanc Biopharma (PPCB) P/E from Jun 30, 2020 to Jul 20, 2026. The TTM Propanc Biopharma (PPCB) P/E is -2.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Propanc Biopharma (PPCB)

YearP/EChange
2026-2.77-89.71%
2025-26.92+93375.18%
2024-0.03-91.85%
2023-0.35-86.44%
2022-2.60-101.10%
2021236.61-84.29%
20201.51KN/A

Comparison Propanc Biopharma (PPCB) P/E with competitors

Propanc Biopharma (PPCB) P/E is -2.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.16%
ENLVEnlivex Ltd0.07-102.70%
FGENFibroGen Inc0.24-108.67%
CHRSCoherus Biosciences Inc0.85-130.65%
FBIOFortress Biotech Inc0.95-134.27%
ORMPOramed Pharmaceuticals Inc1.50-154.28%
AGENAgenus Inc3.01-208.69%
INVAInnoviva Inc3.15-213.91%
VXRTVaxart Inc3.55-228.20%
CRMDCorMedix Inc3.63-231.04%
CVACCureVac N.V.4.45-260.56%
GLPGGalapagos NV4.86-275.48%
SRPTSarepta Therapeutics Inc4.88-276.32%
ABEOAbeona Therapeutics Inc5.39-294.57%
ABUSArbutus Biopharma Corp5.60-302.09%
ZVRAZevra Therapeutics Inc5.89-312.62%
SPROSpero Therapeutics Inc6.23-324.94%
CGENCompugen Ltd6.31-328.03%
RIGLRigel Pharmaceuticals6.87-348.19%
SLXNSilexion Therapeutics Corp7.30-363.50%
OMEROmeros Corporation9.26-434.38%
AUPHAurinia Pharmaceuticals Inc9.58-446.17%
PLXProtalix BioTherapeutics Inc10.89-493.33%
ACADAcadia Pharmaceuticals Inc11.73-523.58%
TBPHTheravance Biopharma Inc12.26-542.85%
ADMAAdma Biologics Inc12.42-548.49%
HRMYHarmony Biosciences Holdings Inc13.82-599.12%
SABSSAB Biotherapeutics Inc14.14-610.54%
NAGENiagen Bioscience Inc14.82-635.17%
INCYIncyte Corp15.82-671.44%
REGNRegeneron Pharmaceuticals Inc15.86-672.67%
PBYIPuma Biotechnology Inc17.32-725.37%
CPRXCatalyst Pharmaceuticals Inc17.44-729.83%
EXELExelixis Inc17.54-733.40%
TGTXTG Therapeutics Inc18.97-784.97%
MDXGMimedx Group Inc20.55-842.27%
XOMAXOMA Royalty Corp22.87-926.16%
ARGXArgen X SE24.30-977.56%
CTMXCytomX Therapeutics Inc24.82-996.45%
XOMAOXOMA Royalty Corp25.34-1015.37%
HALOHalozyme Therapeutics Inc25.62-1025.44%
XOMAPXOMA Royalty Corp25.67-1027.12%
VRTXVertex Pharmaceuticals Inc27.99-1111.07%
RPRXRoyalty Pharma plc - Class A28.69-1136.10%
SLNOSoleno Therapeutics Inc29.02-1147.93%
ASNDAscendis Pharma A/S30.09-1186.59%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1469.25%
APLSApellis Pharmaceuticals Inc39.02-1509.31%
BMRNBiomarin Pharmaceutical Inc42.21-1624.55%
KRYSKrystal Biotech Inc45.34-1737.65%
ONCBeiGene Ltd69.54-2611.56%
PHARPharming Group N.V.75.03-2809.67%
TECHBio-Techne Corp101.96-3782.39%
VCELVericel Corp109.92-4069.98%
ALNYAlnylam Pharmaceuticals Inc117.96-4360.50%
GMABGenmab140.29-5166.82%
TLXTelix Pharmaceuticals Ltd162.15-5956.41%
CORTCorcept Therapeutics Inc212.86-7787.69%